AzTrials
AzTrials

Root CoverageNCT04942821

The Evaluation Clinical Results of Coronally Advanced Flap With Platelet Rich Fibrin

A study testing Platelet rich fibrin and coronally advanced flap and Connective tissue graft and coronally advanced flap in people with Root Coverage, run by Marmara University.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study was to evaluate the clinical outcomes of platelet- rich fibrin and coronally advanced flap technique in the treatment of multiple gingival recessions in comparison with connective tissue graft technique. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Root Coverage
What is being tested?
Platelet rich fibrin and coronally advanced flap and Connective tissue graft and coronally advanced flap
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
12 participants
Where
No sites listed yet
Study dates
23 Apr 2014to 24 Feb 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Patients had at two quadrants, adjacent Miller Class I and at least 2 mm or deeper recessions
  • Full mouth plaque score 20% and Full mouth bleeding on probing 10%
  • no active periodontal disease,
  • involving incisors, canines and premolars,
  • age ≥ 18 years

Who cannot join

  • Patients with general diseases which could affect healing process,
  • smokers
  • Patients had undergone periodontal surgery during the pervious 24 months on the involved sites,
  • pregnant or breastfeeding women
  • endodontic lesions or non-detectable cemento-enamel junctions at experimental teeth

About this study

Official title: Treatment of Multiple Adjacent Gingival Recessions With Coronally Advanced Flap in Combination With Platelet-Rich Fibrin: A Split-Mouth Study

The aim of this study was to evaluate the clinical outcomes of platelet- rich fibrin and coronally advanced flap technique in the treatment of multiple gingival recessions in comparison with connective tissue graft technique.

Read the detailed description

Aim of this study was to evaluate the clinical outcomes of platelet rich fibrin (PRF)+coronally advanced flap (CAF) technique in the treatment of multiple gingival recessions in comparison with connective tissue graft (CTG)+CAF technique.12 patients with bilateral Miller Class I multiple gingival recessions were treated with PRF+CAF (test group) and CTG+CAF (control group) technique in a split-mouth study design. Probing depth, recession depth (RD), clinical attachment level (CAL), recession width, position of gingival margin, papilla width, keratinized tissue height (KTH), keratinized tissue thickness (KTT) were measured at baseline and 3, 6 and 12 months after surgery. Root coverage (RC) and complete root coverage (CRC) ratios were evaluated post-operatively.

Conditions
Root Coverage
Being tested
Platelet rich fibrin and coronally advanced flap, Connective tissue graft and coronally advanced flap
Keywords
Gingival recession, Plastic surgery, Platelet rich fibrin, Connective tissue graft, Coronally advanced flap
Medical subject headings
Gingival Recession

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Platelet rich fibrin and coronally advanced flapProcedure or surgery

    CAF were used in treatment arms. Root planning was performed on the exposed part of roots to provide more biocompatible surface for re-attachment. Two 10 cc tubes with clot activator were used to collect blood from the patient; blood was centrifuged at 2700 rpm for 12 min. PRF box was used to form fibrin clots into membranes. PRF was positioned at the level of the cemento-enamel junction (CEJ), and sutured on the periosteum bed with 6/0 absorbable sutures. Gingival margins on the flap were placed at least 1 mm coronally of the CEJ and sutured with 5/0 absorbable sutures. Sutures were removed at 2nd week.

  • Connective tissue graft and coronally advanced flapProcedure or surgery

    Control sites were treated by coronally advanced flap (CAF) combined with connective tissue graft (CTG). CAF were used in both treatment arms. Root planning was performed on the exposed part of roots to provide more biocompatible surface for re-attachment. CTG was obtained with single incision method. CTG was positioned at the level of the cemento-enamel junction (CEJ), and sutured on the periosteum bed with 6/0 absorbable sutures. Gingival margins on the flap were placed at least 1 mm coronally of the CEJ and sutured with 5/0 absorbable sutures. Sutures were removed at 2nd week.

Study groups in NCT04942821
Study groupRoleWhat they receive
Platelet rich fibrin and coronally advanced flapExperimentalCoronally advanced flap and platelet rich fibrin were used in treatment arms.
Receives: Procedure: Platelet rich fibrin and coronally advanced flap
Connective tissue graft and coronally advanced flapActive comparatorCoronally advanced flap and connective tissue graft were used in treatment arms.
Receives: Procedure: Connective tissue graft and coronally advanced flap

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Percentage of Root Coverage

    The percentage of root coverage was calculated according to the preoperative recession depth to postoperative recession depth.

    Measured: 12 months

Secondary outcomes (7)
  1. Complete Root Coverage

    Complete root coverage was calculated according to measurement of the pre and post operative gingival margin which was above the enamel-sement junction.

    Measured: 12 months

  2. Change from Baseline Keratinized Tissue Width at 3 months

    Width of keratinized tissue at mid-buccal point measured from free gingival margin to mucogingival junction

    Measured: 3 months

  3. Change from Baseline Keratinized Tissue Width at 6 months

    Width of keratinized tissue at mid-buccal point measured from free gingival margin to mucogingival junction

    Measured: 6 months

  4. Change from Baseline Keratinized Tissue Width at 12 months

    Width of keratinized tissue at mid-buccal point measured from free gingival margin to mucogingival junction

    Measured: 12 months

  5. Change from Baseline Gingival Thickness at 3 months

    Gingival thickness at mid-buccal aspect measured at the center of keratinized tissue.

    Measured: 3 months

  6. Change from Baseline Gingival Thickness at 6 months

    Gingival thickness at mid-buccal aspect measured at the center of keratinized tissue.

    Measured: 6 months

  7. Change from Baseline Gingival Thickness at 12 months

    Gingival thickness at mid-buccal aspect measured at the center of keratinized tissue.

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Jun 2021
  2. Study start23 Apr 2014
  3. Primary completion24 Feb 2017
  4. Study completion24 Feb 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
12 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04942821
Sponsor's protocol ID
22-04-2014/418
Status last verified
Mar 2019
First submitted
7 Jun 2021
Last updated
29 Jun 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Yavuz A, Gungormek HS, Kuru L, Dogan B. Treatment of multiple adjacent gingival recessions using leucocyte- and platelet-rich fibrin with coronally advanced flap: a 12-month split-mouth controlled randomized clinical trial. Clin Oral Investig. 2024 May 1;28(5):291. doi: 10.1007/s00784-024-05694-3.

    PubMed 38691209

Questions about this trial

What is this clinical trial studying?

A study testing Platelet rich fibrin and coronally advanced flap and Connective tissue graft and coronally advanced flap in people with Root Coverage, run by Marmara University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Jun 2021. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Percentage of Root Coverage (time frame: 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04942821, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jun 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in